Marianne Welmers

Chapter 2 30 Table 1 Summary of Studies Included in the Meta-Analysis Study Study Quality** Treatment model Treatment setting Type of TA TA Measure Bachler et al. (2016) 30 TAF HB P/Y *** CP-TAF Bennun (1989) 6 FT C P TS Y TS Chinchilla (2007)* 1 27 MDFT n.r. Y VTAS-R Dauber (2004)* 1 25 MDFT n.r. Y VTAS-R Escudero et al. (2008) ^ 24 FT C Y+P SOFTA-O F SOFTA-O Feder & Diamond (2016) 20 ABFT C P VTAS-R Flicker et al. (2008) ^ 22 FFT C Y VTAS-R P VTAS-R S VTAS-R Forsberg et al. (2014) 2 18 FBT C P WAI-O S WAI-O Forsberg et al. (2011)* 2 15 FBT C Y+P WAI-O Friedlander et al. (2008)^ 3 19 FT C F SOFTA-O Friedlander et al. (2012) 3 17 FT C Y SOFTA-S P SOFTA-S Glueckauf et al. (2002) 22 IFCM n.r. Y WAI-S P WAI-S Hawley & Weisz (2005) 29 CB MH C Y TASC P TASC Hogue et al. (2006)^ 1 28 MDFT n.r. Y VTAS-R P VTAS-R Isserlin & Couturier (2012) 18 FBT C Y SOFTA-O P SOFTA-O F SOFTA-O Johnson et al. (2006)^ 4 27 HB FT HB Y+P FTAS Johnson, Wright, & Ketring (2002)^ 4 27 HB FT HB Y FTAS P FTAS Keeley et al. (2011) 27 FB CBT C Y TASC P WAI Kim (2007)* 11 SFBT C Y RRS P RRS Y+P RRS S RRS